ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,857 | +354.2% | 175,819 | +416.2% | 0.02% | +300.0% |
| Q1 2024 | $629 | -93.5% | 34,063 | -89.0% | 0.00% | -94.4% |
| Q4 2023 | $9,723 | +1488.7% | 310,562 | +956.4% | 0.07% | +1083.3% |
| Q3 2023 | $612 | -87.4% | 29,397 | -88.6% | 0.01% | -89.8% |
| Q1 2023 | $4,841 | -99.4% | 257,237 | +360.0% | 0.06% | +555.6% |
| Q2 2022 | $787,000 | -22.4% | 55,918 | +33.5% | 0.01% | +28.6% |
| Q1 2022 | $1,014,000 | -67.7% | 41,898 | -68.8% | 0.01% | -61.1% |
| Q4 2021 | $3,137,000 | +16.6% | 134,429 | +106.0% | 0.02% | -76.9% |
| Q3 2020 | $2,691,000 | -41.7% | 65,259 | -31.5% | 0.08% | -43.9% |
| Q2 2020 | $4,614,000 | – | 95,207 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |